Induction of DARPP-32 by Brain-Derived Neurotrophic Factor in Striatal Neurons In Vitro Is Modified by Histone Deacetylase Inhibitors and Nab2

Abstract

Neurotrophins and modifiers of chromatin acetylation and deacetylation participate in regulation of transcription during neuronal maturation and maintenance. The striatal medium spiny neuron is supported by cortically-derived brain derived neurotrophic factor and is the most vulnerable neuron in Huntington’s disease, in which growth factor and histone deacetylase activity are both disrupted. We examined the ability of three histone deacetylase inhibitors, trichostatin A, valproic acid and Compound 4 b, alone and combined with brain derived neurotrophic factor (BDNF), to promote phenotypic maturation of striatal medium spiny neurons in vitro. Exposure of these neurons to each of the three compounds led to an increase in overall histone H3 and H4 acetylation, dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa (DARPP-32) mRNA and protein, and mRNA levels of other markers of medium spiny neuron maturation. We were, however, unable to prove that HDAC inhibitors directly lead to remodeling of Ppp1r1b chromatin. In addition, induction of DARPP-32 by brain-derived neurotrophic factor was inhibited by histone deacetylase inhibitors. Although BDNF-induced increases in pTrkB, pAkt, pERK and Egr-1 were unchanged by combined application with VPA, the increase in DARPP-32 was relatively diminished. Strikingly, the NGF1A-binding protein, Nab2, was induced by BDNF, but not in the presence of VPA or TSA. Gel shift analysis showed that α-Nab2 super-shifted a band that is more prominent with extract derived from BDNF-treated neurons than with extracts from cultures treated with VPA alone or VPA plus BDNF. In addition, overexpression of Nab2 induced DARPP-32. We conclude that histone deacetylase inhibitors inhibit the induction of Nab2 by BDNF, and thereby the relative induction of DARPP-32.

A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington’s disease mice

“…Thus, treatment of primary striatal cultures with the HDAC1/HDAC3 inhibitor 4b increased the overall levels of H3 and H4 histone acetylation as well as mRNA expression and protein levels of DARPP-32 77 . Similarly, inhibition of HDAC3 in R6/2 transgenic mice with HDACi-136 completely restored the expression of DARPP-32 mRNA levels 10 .…”

Potentially repurposable drugs for schizophrenia identified from its interactome

“…HRH1, targeted by cinnarizine, was predicted to interact with the schizophrenia gene NAB2. NAB2 modifies the induction of DARPP-32, which modulates the response to dopamine in striatal neurons 78 . HRH1 has also been predicted to interact with BBS5, a ciliary protein.…”

Transcriptional and epigenetic characterization of early striosomes identifies Foxf2 and Olig2 as factors required for development of striatal compartmentation and neuronal phenotypic differentiation

“…In spinal cord patterning, TCF7L2 in partnership with Tcf4 can repress Olig2 expression through recruitment of HDAC activity and is required for cell fate specification 105 . Histone deacetylase activity likewise plays a role in MSN maturation 106 . For Olig2, the TF co--expression network highlights Etv5, Mitf, Egr2, Sox10, Olig1, Hey1, and Arntl2, which are also mostly enriched in the EGFP + compartment.…”